Brokerages predict that R1 RCM Inc (NASDAQ:RCM) will announce ($0.02) earnings per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for R1 RCM’s earnings. The highest EPS estimate is ($0.01) and the lowest is ($0.02). R1 RCM reported earnings of ($0.07) per share in the same quarter last year, which indicates a positive year-over-year growth rate of 71.4%. The firm is scheduled to report its next earnings results on Thursday, August 8th.
According to Zacks, analysts expect that R1 RCM will report full-year earnings of $0.10 per share for the current fiscal year, with EPS estimates ranging from $0.02 to $0.17. For the next fiscal year, analysts anticipate that the firm will post earnings of $0.53 per share, with EPS estimates ranging from $0.24 to $0.74. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that that provide coverage for R1 RCM.
R1 RCM (NASDAQ:RCM) last issued its quarterly earnings data on Thursday, May 9th. The financial services provider reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.01. The business had revenue of $275.90 million for the quarter, compared to analyst estimates of $266.37 million. R1 RCM had a negative return on equity of 118.28% and a negative net margin of 2.19%. R1 RCM’s quarterly revenue was up 87.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.26) EPS.
Shares of RCM opened at $11.80 on Tuesday. The firm has a market cap of $1.28 billion, a P/E ratio of -36.88 and a beta of 0.03. R1 RCM has a 12 month low of $7.10 and a 12 month high of $12.50. The stock’s 50-day moving average is $11.62. The company has a debt-to-equity ratio of 118.26, a current ratio of 0.93 and a quick ratio of 0.93.
In other R1 RCM news, Director Charles J. Ditkoff sold 4,099 shares of R1 RCM stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $11.72, for a total transaction of $48,040.28. Following the transaction, the director now directly owns 4,099 shares of the company’s stock, valued at approximately $48,040.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 60.50% of the stock is currently owned by insiders.
Several large investors have recently made changes to their positions in RCM. SCW Capital Management LP acquired a new position in shares of R1 RCM in the 4th quarter valued at about $29,745,000. Millennium Management LLC lifted its stake in shares of R1 RCM by 143.6% in the 4th quarter. Millennium Management LLC now owns 1,968,470 shares of the financial services provider’s stock valued at $15,649,000 after purchasing an additional 1,160,264 shares during the period. Eversept Partners LP lifted its stake in shares of R1 RCM by 39.4% in the 4th quarter. Eversept Partners LP now owns 2,349,306 shares of the financial services provider’s stock valued at $18,677,000 after purchasing an additional 664,219 shares during the period. Royce & Associates LP acquired a new position in shares of R1 RCM in the 4th quarter valued at about $4,492,000. Finally, Eaton Vance Management acquired a new position in shares of R1 RCM in the 4th quarter valued at about $3,384,000. 69.69% of the stock is currently owned by institutional investors.
About R1 RCM
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Further Reading: What economic reports are most valuable to investors?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.